AstraZeneca and eko.ai attempting to meet ‘huge need’ for better heart failure diagnosis

Joris Silon, senior vice president, global cardiovascular, renal and metabolism (CVRM) at AstraZeneca’s biopharmaceuticals business unit (Credit: AstraZeneca)



Related Article
Recommended Whitepaper

View More